Literature DB >> 23216302

Genetic variation in the OX40L/OX40 system and plasma lipid and lipoprotein levels in a Chinese hypertriglyceridemic population.

Rui Liu1, Yan Qiao, Yu Liu, Xian Li, Yucheng Chen, Ou Qiang, Huai Bai.   

Abstract

AIMS: To investigate the variations of OX40 (tumor necrosis factor receptor superfamily, member 4) and its ligand OX40L genes and their relationships with serum lipids and apolipoproteins (apo) levels in Chinese healthy individuals and patients with endogenous hypertriglyceridemia (HTG) in the Chengdu area.
METHODS: The genotypes and allele frequencies of the rs3850641 and rs17568 polymorphisms in the OX40L and OX40 genes were assayed by polymerase chain reaction and restriction fragment length polymorphism.
RESULTS: In the case-control study, which included 126 HTG subjects and 206 normal control subjects, the frequencies of the G allele at the rs3850641 site and the G allele at the rs17568 site in the patients were similar to those observed in the controls. In the HTG group, subjects with G allele carriers of the rs3850641 site had lower serum high-density lipoprotein cholesterol and apo AI levels as compared to those of genotype AA. In the case group, subjects with G allele carriers of the rs17568 site had higher serum low-density lipoprotein cholesterol (LDL-C) levels, while controls had lower serum total serum cholesterol and LDL-C levels.
CONCLUSION: These results suggest that the rs3850641 and rs17568 polymorphisms in the OX40L and OX40 genes are associated with some of the lipid and lipoprotein variations in subjects with endogenous HTG and/or in the general population of Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23216302      PMCID: PMC3582283          DOI: 10.1089/gtmb.2012.0239

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  17 in total

1.  Human genetic evidence that OX40 is implicated in myocardial infarction.

Authors:  Massimiliano Ria; Per Eriksson; Susanna Boquist; Carl-Göran Ericsson; Anders Hamsten; Jacob Lagercrantz
Journal:  Biochem Biophys Res Commun       Date:  2005-11-28       Impact factor: 3.575

2.  Expression and function of OX40 ligand on human dendritic cells.

Authors:  Y Ohshima; Y Tanaka; H Tozawa; Y Takahashi; C Maliszewski; G Delespesse
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

Review 3.  High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.

Authors:  W E Boden
Journal:  Am J Cardiol       Date:  2000-12-21       Impact factor: 2.778

Review 4.  Hepatic lipase: new insights from genetic and metabolic studies.

Authors:  J C Cohen; G L Vega; S M Grundy
Journal:  Curr Opin Lipidol       Date:  1999-06       Impact factor: 4.776

5.  A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians.

Authors:  Zari Dastani; Carole Dangoisse; Betsie Boucher; Katia Desbiens; Larbi Krimbou; Robert Dufour; Robert A Hegele; Päivi Pajukanta; James C Engert; Jacques Genest; Michel Marcil
Journal:  Atherosclerosis       Date:  2005-07-14       Impact factor: 5.162

6.  Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility.

Authors:  Xiaosong Wang; Massimiliano Ria; Peter M Kelmenson; Per Eriksson; David C Higgins; Ann Samnegård; Christina Petros; Jarod Rollins; Anna M Bennet; Björn Wiman; Ulf de Faire; Charlotte Wennberg; Per G Olsson; Naoto Ishii; Kazuo Sugamura; Anders Hamsten; Kristina Forsman-Semb; Jacob Lagercrantz; Beverly Paigen
Journal:  Nat Genet       Date:  2005-03-06       Impact factor: 38.330

7.  Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism.

Authors:  Anders Mälarstig; Per Eriksson; Lynda Rose; Kirsti A Diehl; Anders Hamsten; Paul M Ridker; Robert Y L Zee
Journal:  Clin Chem       Date:  2008-03-20       Impact factor: 8.327

8.  Association of TNFRSF4 gene polymorphisms with essential hypertension.

Authors:  Yoichi Mashimo; Yoichi Suzuki; Kazuko Hatori; Yasuharu Tabara; Tetsuro Miki; Katsushi Tokunaga; Tomohiro Katsuya; Toshio Ogihara; Michiko Yamada; Norio Takahashi; Yoshio Makita; Tomohiro Nakayama; Masayoshi Soma; Nobuhito Hirawa; Satoshi Umemura; Takayoshi Ohkubo; Yutaka Imai; Akira Hata
Journal:  J Hypertens       Date:  2008-05       Impact factor: 4.844

9.  Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor.

Authors:  W R Godfrey; F F Fagnoni; M A Harara; D Buck; E G Engleman
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

10.  CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1.

Authors:  S Flynn; K M Toellner; C Raykundalia; M Goodall; P Lane
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  2 in total

1.  Association of OX40 gene polymorphisms (rs17568G/A and rs229811A/C) with head and neck squamous cell carcinoma.

Authors:  Zahra Faghih; Shabnam Abtahi; Bijan Khademi; Farzaneh Nikfarjam; Nasrollah Erfani
Journal:  Mol Biol Rep       Date:  2019-03-28       Impact factor: 2.316

2.  Lack of Association Between rs17568 Polymorphism in OX40 Gene and Myocardial Infarction, Southern of Iran.

Authors:  Mehrnoosh Maalhagh; Mohammad Shojaei; Saeideh Erfanian; Abdolreza Sotoodeh Jahromi; Mohammad Sadegh Sanie; Alireza Yusefi; Hassan Zabetian; Hossein Hakimelahi; Abdolhossien Madani; Mohammad Hojjat-Farsangi
Journal:  Glob J Health Sci       Date:  2015-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.